drugset / Trial / NCT04025840

Perioperative Epidural Block and Dexamethasone in Pancreatic Cancer Surgery

NCT04025840 ↗

RandomizedFactorialSingle-blindSupportive care

Summary

Pancreatic cancer remains a devastating disease with an average 5-year survival rate of about 3-5%. Previous retrospective studies showed that perioperative epidural block and/or dexamethasone are associated with improved outcome after cancer surgery. This randomized trial aims to investigate the effect of perioperative epidural block and/or dexamethasone on long-term survival in patients following pancreatic cancer surgery.

Timeline

Start
2019-09-11
Primary completion
2024-10-22
Completion
2026-11

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 10 mg Intravenous